West Family Investments’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49 | Buy |
+35,500
| New | +$49 | ﹤0.01% | 367 |
|
|
2025
Q1 | – | Sell |
-35,500
| Closed | -$1.4M | – | 287 |
|
|
2024
Q4 | $1.4M | Hold |
35,500
| – | – | 0.49% | 42 |
|
|
2024
Q3 | $1.67M | Hold |
35,500
| – | – | 0.57% | 28 |
|
|
2024
Q2 | $1.92M | Hold |
35,500
| – | – | 0.57% | 37 |
|
|
2024
Q1 | $2.42M | Hold |
35,500
| – | – | 0.75% | 32 |
|
|
2023
Q4 | $2.22M | Hold |
35,500
| – | – | 0.75% | 32 |
|
|
2023
Q3 | $1.61M | Hold |
35,500
| – | – | 0.56% | 40 |
|
|
2023
Q2 | $1.99M | Hold |
35,500
| – | – | 0.77% | 27 |
|
|
2023
Q1 | $1.61M | Hold |
35,500
| – | – | 0.64% | 38 |
|
|
2022
Q4 | $1.44M | Hold |
35,500
| – | – | 0.49% | 39 |
|
|
2022
Q3 | $2.32M | Hold |
35,500
| – | – | 0.97% | 21 |
|
|
2022
Q2 | $2.16M | Hold |
35,500
| – | – | 0.85% | 22 |
|
|
2022
Q1 | $2.23M | Buy |
+35,500
| New | +$2.23M | 0.63% | 26 |
|